$21.13 B
Share price
Change (1 day)
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Number of shares outstanding for BeiGene (BGNE)

Number of shares outstanding as of September 2023 : 104,166,520

According to BeiGene 's latest financial reports and stock price the company's current number of shares outstanding is 104,166,520. At the end of 2023 the company had 104,166,520 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for BeiGene from 2015 to 2023

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20230.10 B0.39%
20220.10 B9.19%
202195.02 M4.6%
202090.84 M49.7%
201960.68 M2.19%
201859.38 M30.39%
201745.54 M14.78%
201639.67 M25.9%
201531.51 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
751,506,257 621.45%๐Ÿ‡บ๐Ÿ‡ธ USA
20,960,171-79.88%๐Ÿ‡บ๐Ÿ‡ธ USA